Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578


News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 01:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.


- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at inti.landauro@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : SANOFI
React to this article
Latest news on SANOFI
07:37a SANOFI : Voyager Therapeutics Raises USD30 million in Private Placement of Serie..
01:12a LAZARD : Works with sanofi on €12bn animal health unit
01:02a SANOFI : First Doses of Injectable Polio Vaccine ShanIPV(TM) Soon Available for ..
11/28 SANOFI : Boston Pharma appoints ex-Pfizer and Sanofi executives
11/27 EXCLUSIVE : Lazard works with Sanofi on $12.7 billion animal health unit deal - ..
11/27 SANOFI : And regeneron announce 18,000-patient odyssey outcomes trial of praluen..
11/27 SANOFI : And astrazeneca exchange more than 200,000 chemical compounds
11/25 GENZYME : Reports from Genzyme Corporation Advance Knowledge in Drug Development..
11/24 SANOFI : We are Sanofi : - Meet Robert Lowe
11/24 SANOFI : Information concerning the total number of voting rights and shares, pr..
News chart
Full-screen chart
Income Statement Evolution
More Financials